Polymorphism of tmprss2 (rs12329760) and severity of COVID-19 in the Ukrainian population: Response

Polymorphism of tmprss2 (rs12329760) and severity of COVID-19 in the Ukrainian population: Response

Authors

  • Olga Izmailova Scientific Research Institute of Genetic and Immunological Grounds of Pathology and Pharmacogenetic, Poltava State Medical University, Poltava, Ukraine
  • Oksana Shlykova Scientific Research Institute of Genetic and Immunological Grounds of Pathology and Pharmacogenetic, Poltava State Medical University, Poltava, Ukraine
  • Alina Kabaliei Scientific Research Institute of Genetic and Immunological Grounds of Pathology and Pharmacogenetic, Poltava State Medical University, Poltava, Ukraine
  • Anastasia Vatsenko Department of infectious diseases with epidemiology, Poltava State Medical University, Poltava, Ukraine
  • Dmytro Ivashchenko Department of surgery No. 4 with minimally invasive surgery, Poltava State Medical University, Poltava, Ukraine
  • Maksym Dudchenko Department of surgery No. 4 with minimally invasive surgery, Poltava State Medical University, Poltava, Ukraine
  • Andrii Volianskyi Laboratory of Immunorehabilitology, Mechnikov Institute of Microbiology and Immunology, Kharkiv, Ukraine
  • Gennadiy Zelinskyy Institute for Virology, University Medicine Essen, University Duisburg-Essen, Germany
  • Tetiana Koval Department of infectious diseases with epidemiology, Poltava State Medical University, Poltava, Ukraine
  • Ulf Dittmer Institute for Virology, University Medicine Essen, University Duisburg-Essen, Germany
  • Igor Kaidashev Department of Internal Medicine No3 with Phthisiology, Poltava State Medical University, Poltava, Ukraine

Keywords:

COVID-19, Ukrainian population, tmprss2 (rs12329760)

Abstract

.

References

Kaidashev I, Izmailova O, Shlykova O, et al. Polymorphism of tmprss2 (rs12329760) but not ace2 (rs4240157), tmprss11a (rs353163) and cd147 (rs8259) is associated with the severity of COVID-19 in the Ukrainian population. Acta Biomed. 2023 Feb 13;94(1):e2023030. doi: 10.23750/abm.v94i1.13543.

Kaidashev I, Shlykova O, Izmailova O, et al. Host gene variability and SARS-CoV-2 infection: A review article. Heliyon. 2021;7(8):e07863. doi:10.1016/j.heliyon.2021.e07863.

Izmailova O, Shlykova O, Vatsenko A, et al. Allele С (rs5186) of at1r is associated with the severity of COVID-19 in the Ukrainian population. Infect Genet Evol. 2022;98:105227. doi:10.1016/j.meegid.2022.105227.

da Rosa Mesquita R, Francelino Silva Junior LC, Santos Santana FM, et al. Clinical manifestations of COVID-19 in the general population: systematic review. Wien Klin Wochenschr. 2021 Apr;133(7-8):377-382. doi: 10.1007/s00508-020-01760-4.

Baj J, Karakuła-Juchnowicz H, Teresiński G, et al. COVID-19: Specific and Non-Specific Clinical Manifestations and Symptoms: The Current State of Knowledge. J Clin Med. 2020 Jun 5;9(6):1753. doi: 10.3390/jcm9061753.

Patel VK, Shirbhate E, Rajak H. Coronavirus reinfections: An outlook on evidences and effects. Lessons from COVID-19. 2022:19–40. doi: 10.1016/B978-0-323-99878-9.00013-3.

Downloads

Published

24-04-2023

Issue

Section

LETTERS TO THE EDITOR AND CORRESPONDENCE

How to Cite

1.
Izmailova O, Shlykova O, Kabaliei A, Vatsenko A, Ivashchenko D, Dudchenko M, et al. Polymorphism of tmprss2 (rs12329760) and severity of COVID-19 in the Ukrainian population: Response. Acta Biomed [Internet]. 2023 Apr. 24 [cited 2024 Jul. 21];94(2):e2023109. Available from: https://www.mattioli1885journals.com/index.php/actabiomedica/article/view/14423